Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Udveje Behandling Aps Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 23.5% 19.8% 9.6% 7.6% 4.8% 14.9% 14.6%   Credit score (0-100)   0 3 5 25 31 45 14 15   Credit rating   N/A B B BB BB BBB BB BB   Credit limit (kDKK)   6.1 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 -73.0 1,067 1,964 4,873 4,474 0.0 0.0   EBITDA   0.0 -94.3 286 327 1,037 922 0.0 0.0   EBIT   0.0 -94.3 286 312 906 710 0.0 0.0   Pre-tax profit (PTP)   0.0 -95.6 285.9 310.8 896.1 695.9 0.0 0.0   Net earnings   0.0 -74.6 222.3 236.8 710.1 541.3 0.0 0.0   Pre-tax profit without non-rec. items   0.0 -95.6 286 311 896 696 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 275 735 787 0.0 0.0   Shareholders equity total   60.0 -14.6 208 445 775 961 551 551   Interest-bearing liabilities   0.0 121 17.9 27.2 268 177 0.0 0.0   Balance sheet total (assets)   0.0 114 426 1,095 2,557 2,252 551 551   Net Debt   0.0 47.4 -196 -261 -1,025 -345 -551 -551     See the entire balance sheet 1000.0 Volume  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 -73.0 1,067 1,964 4,873 4,474 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 84.1% 148.1% -8.2% -100.0% 0.0%   Employees   0 0 0 3 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 114 426 1,095 2,557 2,252 551 551   Balance sheet change%   0.0% 0.0% 272.3% 157.2% 133.6% -12.0% -75.5% 0.0%   Added value   0.0 -94.3 286.0 326.6 920.6 922.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 260 330 -161 -787 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 129.2% 26.8% 15.9% 18.6% 15.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% -73.2% 103.2% 41.1% 49.6% 29.7% 0.0% 0.0%   ROI %   0.0% -78.0% 165.0% 89.4% 118.8% 64.6% 0.0% 0.0%   ROE %   0.0% -42.8% 138.1% 72.6% 116.5% 62.4% 0.0% 0.0%   1000.0 Solidity  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   100.0% -11.3% 48.8% 40.6% 30.3% 42.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -50.3% -68.5% -79.9% -98.8% -37.4% 0.0% 0.0%   Gearing %   0.0% -829.2% 8.6% 6.1% 34.5% 18.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 2.1% 0.2% 5.6% 6.8% 7.8% 0.0% 0.0%   1000.0 Liquidity  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.0 0.7 2.7 1.1 1.1 1.2 0.0 0.0   Current Ratio   0.0 0.7 2.7 1.1 1.1 1.2 0.0 0.0   Cash and cash equivalent   0.0 73.4 213.9 288.1 1,292.9 522.3 0.0 0.0   1000.0 Capital use efficiency  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 -34.4 252.6 41.9 194.3 202.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 109 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 109 0 0 0 0   EBIT / employee   0 0 0 104 0 0 0 0   Net earnings / employee   0 0 0 79 0 0 0 0